Linifanib

Scientific Overview: Anti-angiogenic multi-kinase inhibitor; AbbVie compound; compared to sorafenib in HCC. VEGFR + FLT3 — dual use in HCC and AML

Mechanism of Action: VEGFR/PDGFR/KIT/FLT3 TKI

Purity: ≥99%  |  Molecular Formula: C22H17FN4O

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.